Topic: How To Invest

Q: Can I get your comments on Cooper Companies (NYSE:COO)? Thank you.

Article Excerpt

A: The Cooper Companies Inc., $264.34, symbol COO on New York (Shares outstanding: 49.3 million; Market cap: $12.8 billion; Manufacturing sector; TSINetwork Rating: Average; www.coopercos.com), is a California-based healthcare business with two operating segments. The first segment is Cooper Vision (75% of revenues); it manufactures and markets soft contact lenses for the vision-correction market worldwide. It specializes in lenses for common eye conditions like astigmatism, presbyopia, and ocular dryness. The second, Cooper Surgical (25%), develops and markets the medical devices, diagnostic products, and surgical instruments and accessories used by gynecologists and obstetricians. In December 2021, Cooper Companies completed the acquisition of Generate Life Sciences for $1.6 billion. Generate Life Sciences was created by GI Partners in 2018 as the combination of California Cryobank Life Sciences, an industry-leading donor sperm and egg bank, and Cord Blood Registry, a leading provider of newborn stem-cell services. The combined firm aimed to serve families from preconception to post-birth. Headquartered in Los Angeles, Generate also operates facilities in Tucson, New…